Biofil Chemicals and Pharmaceuticals Limited

BSE:524396 Stock Report

Market Cap: ₹921.6m

Biofil Chemicals and Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ramesh Shah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure40yrs
CEO ownership4.9%
Management average tenureno data
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO

Ramesh Shah (88 yo)

40yrs

Tenure

Mr. Ramesh S. Shah serves as the Managing Director and CEO of Biofil Chemicals & Pharmaceuticals Ltd. and served as its Compliance Officer. Mr. Shah serves as the Chairman of Biofil Chemicals & Pharmaceuti...

Board Members

NamePositionTenureCompensationOwnership
Ketan Shah
COO & Whole Time Director4.4yrs₹1.74m2.83%
₹ 26.1m
Ramesh Shah
Chairman40yrsno data4.88%
₹ 45.0m
Ashok Ramawat
Independent Non Executive Director4.4yrsno datano data
Satish Beohar
Independent Non Executive Director3.6yrsno datano data
Gayatri Padiyar
Non-Executive Independent Director1.4yrsno datano data

4.4yrs

Average Tenure

63yo

Average Age

Experienced Board: 524396's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 01:07
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofil Chemicals and Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution